Jeff Chen

Jeff Chen is Managing Director and Head of Healthcare at Alkeon Capital Management LLC, based in New York, NY, where he leads investment efforts across the healthcare and life sciences sectors. His primary responsibilities include sourcing and overseeing investments in biotechnology, pharmaceuticals, diagnostics, medical devices, tools, contract research organizations, and contract development and manufacturing organizations.

Before joining Alkeon Capital, Jeff served as Vice President and Research Analyst at Cowen, specializing in biotech equity research. He has held research positions at the Max Planck Institute in Germany and the Howard Hughes Medical Institute, reflecting over a decade of academic and industry experience in life sciences.

Jeff holds a Ph.D. in Cellular Molecular Medicine and Neuroscience from Johns Hopkins University and a B.S. from Penn State University. He is recognized for his significant contributions to bridging scientific innovation and investment, notably influencing strategic decisions as a board member at Alto Neuroscience and leveraging his expertise in neurocognitive science and gene therapy research to advance growth in cutting-edge healthcare technologies.